Partner Headlines - GSK

  1. Weekly 3-Year Low Highlights: RDS.B, GSK, WPZ, CLR

    GuruFocus
  2. Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines

    Benzinga
  3. Pfizer Spreading Its Wings Into A New Domain Of Life Sciences

    GuruFocus
  4. Merck Bets $9.5 Billion On Cubist's War On Superbugs

    IBD
  5. GlaxoSmithKline's Move A Testament That Pharma Companies Are ...

    Benzinga
  6. The Top 5 European Stocks Held During Q3

    GuruFocus
  7. BioMarin buying Prosensa

    IBD
  8. BioMarin Buying Prosensa, Backing Up Troubled Drug

    IBD
  9. Screening Pharma Stocks Amid Turnaround

    YCharts
  10. Jeff Auxier Buys Berkshire Hathaway in Third Quarter

    GuruFocus
  11. Apollo may make Glaxo offer

    IBD
  12. Irving Kahn Starts New Position In GlaxoSmithKline

    GuruFocus
  13. Irving Kahn Buys Stake in GlaxoSmithKline During Q3 2014

    GuruFocus
  14. Insys Q3 Beats Estimates, Helping Stock Rebound

    IBD
  15. Kahn Brothers' Third Quarter Numbers

    GuruFocus
  16. Ebola Vaccine Contenders

    Benzinga
  17. Stock Futures Upshift On Data; Yahoo, Broadcom, Boeing Climb

    IBD
  18. Benzinga Weekly Preview: Earnings Season Is In Full Swing

    Benzinga
  19. Diamond Hill Capital Comments on GlaxoSmithKline PLC

    GuruFocus
  20. Sarepta Therapeutics Shares Up On Ebola Drug Safety Study

    Benzinga
  21. Hazmat Suit Maker Lakeland Soars On Dallas Ebola Fear

    IBD
  22. Ebola-Related Pharma Stocks Soar On First U.S. Case

    IBD
  23. Action Heats Up in Ebola-Related Equities

    FoxBusiness
  24. Guru Stocks at 52-Week Lows: BHP, GSK, UTX, SAP, TEF

    GuruFocus
  25. Pharma Stocks: Surprising Shift In U.S. Drug Market

    YCharts
  26. Royal Bank of Scotland

    IBD
  27. Gilead's New HIV Drug Key To Long-Term Strategy

    IBD
  28. International Securities For A Diversified Income Portfolio

    GuruFocus
  29. Could European Funds Offer An Opportunity Now?

    Benzinga
  30. Widely Held Guru Stocks Trading In Europe

    GuruFocus
  31. 3 Partnerships Pushing The Pharmaceutical Sector Forward

    Benzinga
  32. Guru Stocks at 52-Week Lows: BHP, GSK, EC, VALE, ABB

    GuruFocus
  33. China Fines Glaxo For Bribes

    IBD
  34. Guru Stocks at 52-Week Lows: BHP, GSK, VOD, LYG, TEF

    GuruFocus
  35. Stock Futures Down, But Not Far; Alibaba Sets IPO Price Range

    IBD
  36. Benzinga's M&A Chatter for Wednesday August 27, 2014

    Benzinga
  37. GSK Receives FDA Approval Of An Additional Promacta (eltrombopag) ...

    Benzinga
  38. InterMune Stock Spikes On Rare Big Biotech Buyout

    IBD
  39. 3 Dividend Kings From The U.K. I Love To Buy

    GuruFocus
  40. UPDATE: GlaxoSmithKline Receives FDA Approval For Arnuity Ellipta ...

    Benzinga
  41. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, MFG

    GuruFocus
  42. Intermune up on buyout buzz

    IBD
  43. You Should Consider Adding GlaxoSmithKline Based on Tremendous ...

    GuruFocus
  44. Drugmaker AstraZeneca Returns To Growth

    IBD
  45. Widely Held Guru Stocks Near 52-Week Lows

    GuruFocus
  46. Pfizer To Buy Baxter's Vaccines For $635 Million: The Positives ...

    Benzinga
  47. Glaxo, Sanofi Trend Up On Potential Deal For Established Brands

    Benzinga
  48. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, UBS

    GuruFocus
  49. Glaxo, Genmab Report Positive Interim Result for Phase III Study ...

    Benzinga
  50. A Look at the Week's Top Dividend Growers

    GuruFocus
  51. Markets Little Changed Ahead Of The Federal Reserve's Policy ...

    Benzinga
  52. GlaxoSmithKline

    IBD
  53. Stock Futures Up, But Wobbly; Boeing, Apple, Biogen Rising

    IBD
  54. Mylan Wins Motion To Enjoin GlaxoSmithKline From Providing Paroxetine ...

    Benzinga
  55. Morning Market Movers

    Benzinga
  56. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With ...

    Benzinga
  57. Highest Yielding Stocks Widely Held By The Gurus

    GuruFocus
  58. British Stocks: Sweet Spot For European Value

    YCharts
  59. Diamond Hill Capital Comments on GlaxoSmithKline PLC

    GuruFocus
  60. ISIS Pharma Trades Up Premarket; NYT Says Has Potential Heart ...

    Benzinga
  61. Advances In HIV, Hep C Treatments Could Spark Renewed Interest ...

    Benzinga
  62. InterMune Up On Bullish View Of U.S. Esbriet Launch

    IBD
  63. UPDATE: Glaxo, Theravance Report Positive Data from Two Studies ...

    Benzinga
  64. Major British Companies Lead Top Guru-Held UK and Ireland Stocks ...

    GuruFocus
  65. ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

    Benzinga
  66. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica ...

    Benzinga
  67. Aura Of Light Shines On Pernix Shares Following Treximet Acquisition

    Benzinga
  68. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  69. Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry

    Benzinga
  70. Can Pfizer Make Up Its Loss?

    GuruFocus
  71. Merck Sells Consumer Unit To Bayer To Focus On R&D

    IBD
  72. Bayer Buys Merck Consumer Care Unit

    FoxBusiness
  73. AstraZeneca Rejects Pfizer's $106B Buyout Bid

    FoxBusiness
  74. #PreMarket Primer: Thursday, May 1: Fed Brushes Off Dissapointing ...

    Benzinga
  75. Glaxo hurt by Advair scandal

    IBD
  76. Nasdaq Leads Early Stock Slide; Twitter Tumbles, Trinity Rises

    IBD
  77. Stock Futures Slip as Traders Brace for Economic Flood

    FoxBusiness
  78. Disappointing GDP Reading Weighs on Stocks

    FoxBusiness
  79. China Rule Change Further Opens Yuan To World Markets

    IBD
  80. Weekly 52-Week Highs Highlight: AV, XEL, OKE, GSK

    GuruFocus
  81. GSK, MMV Announce Commencement of Phase III Programme of Tafenoquine ...

    Benzinga
  82. These Three Pharmaceutical Companies Shake The Market With Their ...

    GuruFocus
  83. Benzinga Weekly Preview: Earnings Season Continues As Biotech ...

    Benzinga
  84. Big Pharmas Swap Specialties

    IBD
  85. Drugmakers Prod European Stocks To Post-Easter Rally

    IBD
  86. Valeant's Bid For Allergan Boosts Ethical Drug Stocks

    IBD
  87. Novartis, Glaxo Swap Units; Valeant Bids For Allergan

    IBD
  88. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  89. S&P 500, Nasdaq Rise For Sixth Day As Volume Picks Up

    IBD
  90. Pharma Deal Frenzy: A Bid to Boost Profits, Cut Risk

    FoxBusiness
  91. Amgen Slumps After 1Q Earnings Miss

    FoxBusiness
  92. Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)

    Benzinga
  93. Novartis, Glaxo Swap Units; Lilly Buying Animal Biz

    IBD
  94. Stock Futures Mixed And Busy; Allergan, Netflix, Glaxo Climb

    IBD
  95. Novartis Announces Multi-Billion-Dollar Revamp

    FoxBusiness
  96. US Stock Futures Edge Higher Ahead Of McDonald's Earnings

    Benzinga
  97. Stock Futures Steady Amid Raft of Health M&A

    FoxBusiness
  98. Wall Street Ticks Up as Traders Parse News Deluge

    FoxBusiness
  99. GlaxoSmithKline Finally Received Approval from FDA for Its Diabetes ...

    GuruFocus
  100. Has A Streamlined FDA Raised The Value Of Drug Stocks?

    IBD
Trading Center